As Europe braces for another long, hot summer, some regions and communities are at greater risk of harm, writes James C. Reynolds ...
The trial missed its primary endpoint but showed the test can detect cancers earlier, fueling questions around the best framework to evaluate MCED tests.
Roswell Park researchers at ASCO 2026 report GLP-1 links to breast cancer risk, CAR T safety in older myeloma patients, and ...
Pfizer Inc. today announced detailed results from the pivotal Phase 3 TALAPRO-3 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results